Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-05-15 @ 5:51 AM
Study NCT ID:
NCT01844518
Status:
COMPLETED
Last Update Posted:
2023-07-12
First Post:
2013-04-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IM101-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None